J7302 – Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ7302
- Long description
- Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
- Short description
- Levonorgestrel iu 52 mg
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
SNon-covered by Medicare statute- BETOS category
P6CMinor procedures - other (Medicare fee schedule)- Added
- January 1, 2002
- Last change
- January 1, 2016 – No change
- Termination date
- December 31, 2015
Frequently asked questions
What is HCPCS code J7302?
J7302 is a HCPCS Level II code for levonorgestrel-releasing intrauterine contraceptive system, 52 mg. It was discontinued on December 31, 2015.
Does Medicare cover J7302?
The HCPCS file lists coverage code S: Non-covered by Medicare statute. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7294 – Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each
- J7295 – Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
- J7296 – Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg
- J7297 – Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg
- J7298 – Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg
- J7299 – Intrauterine copper contraceptive (miudella)
- J7300 – Intrauterine copper contraceptive (paragard)
- J7301 – Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
- J7303 – Contraceptive supply, hormone containing vaginal ring, each
- J7304 – Contraceptive supply, hormone containing patch, each
- J7306 – Levonorgestrel (contraceptive) implant system, including implants and supplies
- J7307 – Etonogestrel (contraceptive) implant system, including implant and supplies
- J7308 – Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
- J7309 – Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
- J7310 – Ganciclovir, 4.5 mg, long-acting implant
- J7311 – Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.